Advertisement
Reassurance from the lipid outcomes trial with the highest percentage female enrollment to date
Tech-assisted self-selection concurred with clinician-assessed eligibility in >90% of cases
OMT may be right for some with Graves’ eye disease
Surprise findings argue for caution about testosterone use in men at risk for fracture
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Perserverance may depend on several specifics, including medication type, insurance coverage and medium-term weight loss
Newly identified pathway may explain the so-called niacin paradox
It's time to increase testing for this major cardiovascular risk factor in advance of new therapies
Findings establish overweight/obesity as a modifiable risk factor for cardiovascular disease
Undetectable levels achieved for nearly nine months in phase 1 trial
Study sheds light on how clinicians addressed their patients’ pain and insomnia during the pandemic
Advertisement
Advertisement